A B S T R A C TOver the last decade, there has been a huge upsurge of interest in sustainable production of biomass-based biofuels to fulfill the existing energy demand and simultaneously reducing the environmental deterioration. Earlier, vegetable oils and animal fats were utilized for biodiesel production, but due to food crisis and environmental sustainability, renewable sources such as neutral lipid derived from microbes are gaining much attention for budding biodiesel industries. Among various types of microorganisms, oleaginous yeasts are more promising feedstock to accomplish the current demand of biodiesel production and utilize a large number of cost-effective renewable substrates for their growth and lipid accumulation. However, biodiesel obtained from oleaginous yeasts have certain restrictions regarding their commercial utilization due to their unstable fuel properties such as oxidative stability, cetane number, viscosity and low-temperature performance etc. Numerous articles have been published in the public domain describing the fatty acid profiles of oleaginous yeast as feedstock for biodiesel production. However, the evaluation of quality parameters of biodiesel obtained from oleaginous yeasts is still in infancy. Although there is a huge disparity in a number of papers published for biodiesel production yet the reporting performance on diesel engines need to be verified in details. In this review article, attempt has been made to assess the important biofuel properties on the basis of the fatty acid profile of oleaginous yeast. Thus this evaluation would provide a guideline to the biodiesel producer to improve the production plans related to feedstocks for oleaginous yeast, culture conditions and biodiesel blending.
Cryptococcosis is an emerging and recalcitrant systemic infection occurring in immunocompromised patients. This invasive fungal infection is difficult to treat due to the ability of Cryptococcus neoformans and Cryptococcus laurentii to form biofilms resistant to standard antifungal treatment. The toxicity concern of these drugs has stimulated the search for natural therapeutic alternatives. Essential oil and their active components (EO-ACs) have shown to possess the variety of biological and pharmacological properties. In the present investigation the effect of six (EO-ACs) sourced from Oregano oil (Carvacrol), Cinnamon oil (Cinnamaldehyde), Lemongrass oil (Citral), Clove oil (Eugenol), Peppermint oil (Menthol) and Thyme oil (thymol) against three infectious forms; planktonic cells, biofilm formation and preformed biofilm of C. neoformans and C. laurentii were evaluated as compared to standard drugs. Data showed that antibiofilm activity of the tested EO-ACs were in the order: thymol>carvacrol>citral>eugenol=cinnamaldehyde>menthol respectively. The three most potent EO-ACs, thymol, carvacrol, and citral showed excellent antibiofilm activity at a much lower concentration against C. laurentii in comparison to C. neoformans indicating the resistant nature of the latter. Effect of the potent EO-ACs on the biofilm morphology was visualized using scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM), which revealed the absence of extracellular polymeric matrix (EPM), reduction in cellular density and alteration in the surface morphology of biofilm cells. Further, to realize the efficacy of the EO-ACs in terms of human safety, cytotoxicity assays and co-culture model were evaluated. Thymol and carvacrol as compared to citral were the most efficient in terms of human safety in keratinocyte- Cryptococcus sp. co-culture infection model suggesting that these two can be further exploited as cost-effective and non-toxic anti-cryptococcal drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.